Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unlimit Health is an international non-profit organization dedicated to the elimination of parasitic infections, specifically schistosomiasis and soil-transmitted helminthiasis. Formerly known as the Schistosomiasis Control Initiative (SCI) Foundation, the organization partners with governments in sub-Saharan Africa to design, implement, and monitor large-scale treatment programs. They focus on strengthening health systems and providing technical assistance to ensure the sustainable delivery of preventative chemotherapy. By leveraging data and research, Unlimit Health aims to reduce the global burden of neglected tropical diseases and improve the health and well-being of affected communities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unlimit Health.